Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 28, 2024	Sep. 30, 2023
Current assets:
Cash and cash equivalents	$ 625,860	$ 667,570
Accounts receivable, net of allowances of approximately $7 million and $8 million as of September 28, 2024 and September 30, 2023, respectively	1,337,562	1,230,771
Contract assets	384,077	445,757
Inventories	1,443,629	1,477,223
Prepaid expenses and other current assets	79,301	58,249
Total current assets	3,870,429	3,879,570
Property, plant and equipment, net	616,067	632,836
Deferred income tax assets	160,703	177,597
Other	175,646	183,965
Total assets	4,822,845	4,873,968
Current liabilities:
Accounts payable	1,441,984	1,559,293
Accrued liabilities	348,066	320,688
Accrued payroll and related benefits	133,129	127,406
Short-term debt, including current portion of long-term debt	17,500	25,945
Total current liabilities	1,940,679	2,033,332
Long-term liabilities:
Long-term debt	299,823	312,327
Other	220,835	209,684
Total long-term liabilities	520,658	522,011
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.01 par value, authorized 5,000 shares, none issued and outstanding	0	0
Common stock, $0.01 par value, authorized 166,667 shares; 113,117 and 111,550 shares issued and 53,921 and 56,833 shares outstanding as of September 28, 2024 and September 30, 2023, respectively	539	568
Treasury stock, 59,196 and 54,718 shares as of September 28, 2024 and September 30, 2023, respectively, at cost	(1,739,550)	(1,485,252)
Additional paid-in capital	6,576,360	6,512,763
Accumulated other comprehensive income	66,741	70,879
Accumulated deficit	(2,707,472)	(2,930,008)
Noncontrolling interest	164,890	149,675
Equity, Including Portion Attributable to Noncontrolling Interest, Total	2,361,508	2,318,625
Total liabilities and stockholders' equity	$ 4,822,845	$ 4,873,968